Free Trial
ASX:COH

Cochlear (COH) Stock Price, News & Analysis

Cochlear logo

About Cochlear Stock (ASX:COH)

Key Stats

Today's Range
N/A
50-Day Range
N/A
52-Week Range
N/A
Volume
201,277 shs
Average Volume
N/A
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
1.44%
Price Target
N/A
Consensus Rating
N/A

Company Overview

Cochlear Limited provides implantable hearing solutions for children and adults worldwide. It offers cochlear implant systems, sound processor upgrades, bone conduction systems, accessories, and other products. The company was founded in 1981 and is headquartered in Sydney, Australia.

Receive COH Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Cochlear and its competitors with MarketBeat's FREE daily newsletter.

COH Stock News Headlines

Cochlear Limited Announces Continued Share Buy-Back
Cochlear Limited Director Boosts Securities Holdings
What This Post-Election Shift Means for Your Investments
The election may be over, but its impact on financial markets is only beginning. New trends are emerging, bringing both challenges and opportunities for investors. Many of these changes are flying under the radar, yet they have the potential to reshape the financial landscape for years to come. Understanding how these shifts could affect your wealth—and what steps to take—has never been more important.
Cochlear Limited Announces New Equity Issuance
Cochlear Limited Updates on Share Buy-Back Program
Cochlear Limited Updates on Share Buy-back Progress
Cochlear Limited Announces Director’s Stock Transactions
Cochlear Limited Announces New Share Issuance
See More Headlines

COH Stock Analysis - Frequently Asked Questions

Cochlear Limited (ASX:COH) announced its quarterly earnings results on Tuesday, February, 19th. The company reported $2.15 EPS for the quarter, missing analysts' consensus estimates of $2.19 by $0.04. Cochlear had a trailing twelve-month return on equity of 19.88% and a net margin of 15.96%.

Based on aggregate information from My MarketBeat watchlists, some other companies that Cochlear investors own include CSL (CSL), ResMed (RMD), NIB (NHF), Accent Group (AX1), Corporate Travel Management (CTD), Mineral Resources (MIN) and Technology One (TNE).

Company Calendar

Last Earnings
2/19/2019
Ex-Dividend for 10/9 Dividend
9/16/2024
Dividend Payable
10/09/2024
Today
11/21/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Medical Devices
Sub-Industry
N/A
CIK
N/A
Fax
N/A
Employees
4,996
Year Founded
N/A

Profitability

Net Income
$356.80 million
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$2.24 billion
Book Value
A$28.10 per share

Miscellaneous

Free Float
N/A
Optionable
Not Optionable
Beta
0.47
7 Stocks to Own Before the 2024 Election Cover

Looking to avoid the hassle of mudslinging, volatility, and uncertainty? You'd need to be out of the market, which isn’t viable. So where should investors put their money? Find out with this report.

Get This Free Report

This page (ASX:COH) was last updated on 11/22/2024 by MarketBeat.com Staff
From Our Partners